nodes	percent_of_prediction	percent_of_DWPC	metapath
Linagliptin—ABCB1—Sorafenib—liver cancer	0.249	0.389	CbGbCtD
Linagliptin—ABCB1—Doxorubicin—liver cancer	0.151	0.236	CbGbCtD
Linagliptin—CYP3A4—Sorafenib—liver cancer	0.149	0.233	CbGbCtD
Linagliptin—CYP3A4—Doxorubicin—liver cancer	0.0905	0.141	CbGbCtD
Linagliptin—Skin exfoliation—Sorafenib—liver cancer	0.0131	0.0439	CcSEcCtD
Linagliptin—Pain in extremity—Sorafenib—liver cancer	0.00994	0.0334	CcSEcCtD
Linagliptin—Nasopharyngitis—Sorafenib—liver cancer	0.00889	0.0298	CcSEcCtD
Linagliptin—Pancreatitis—Sorafenib—liver cancer	0.00842	0.0283	CcSEcCtD
Linagliptin—Infestation—Sorafenib—liver cancer	0.00766	0.0257	CcSEcCtD
Linagliptin—Infestation NOS—Sorafenib—liver cancer	0.00766	0.0257	CcSEcCtD
Linagliptin—Hyperlipidaemia—Epirubicin—liver cancer	0.00702	0.0236	CcSEcCtD
Linagliptin—Hyperlipidaemia—Doxorubicin—liver cancer	0.0065	0.0218	CcSEcCtD
Linagliptin—Immune system disorder—Sorafenib—liver cancer	0.00621	0.0209	CcSEcCtD
Linagliptin—Mediastinal disorder—Sorafenib—liver cancer	0.0062	0.0208	CcSEcCtD
Linagliptin—Malnutrition—Sorafenib—liver cancer	0.00599	0.0201	CcSEcCtD
Linagliptin—Angioedema—Sorafenib—liver cancer	0.00547	0.0184	CcSEcCtD
Linagliptin—Cough—Sorafenib—liver cancer	0.00522	0.0175	CcSEcCtD
Linagliptin—Myalgia—Sorafenib—liver cancer	0.0051	0.0171	CcSEcCtD
Linagliptin—Arthralgia—Sorafenib—liver cancer	0.0051	0.0171	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00506	0.017	CcSEcCtD
Linagliptin—Anaphylactic shock—Sorafenib—liver cancer	0.00489	0.0164	CcSEcCtD
Linagliptin—Infection—Sorafenib—liver cancer	0.00485	0.0163	CcSEcCtD
Linagliptin—Skin exfoliation—Epirubicin—liver cancer	0.00483	0.0162	CcSEcCtD
Linagliptin—Skin disorder—Sorafenib—liver cancer	0.00474	0.0159	CcSEcCtD
Linagliptin—Skin exfoliation—Doxorubicin—liver cancer	0.00447	0.015	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00445	0.0149	CcSEcCtD
Linagliptin—Diabetes mellitus—Epirubicin—liver cancer	0.00422	0.0142	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Sorafenib—liver cancer	0.00422	0.0142	CcSEcCtD
Linagliptin—CYP3A4—Felbamate Metabolism—CYP2E1—liver cancer	0.0042	0.0672	CbGpPWpGaD
Linagliptin—Constipation—Sorafenib—liver cancer	0.00418	0.014	CcSEcCtD
Linagliptin—Diabetes mellitus—Doxorubicin—liver cancer	0.00391	0.0131	CcSEcCtD
Linagliptin—Urticaria—Sorafenib—liver cancer	0.00388	0.013	CcSEcCtD
Linagliptin—Hypoglycaemia—Epirubicin—liver cancer	0.00376	0.0126	CcSEcCtD
Linagliptin—Pain in extremity—Epirubicin—liver cancer	0.00367	0.0123	CcSEcCtD
Linagliptin—Hypersensitivity—Sorafenib—liver cancer	0.0036	0.0121	CcSEcCtD
Linagliptin—Hypoglycaemia—Doxorubicin—liver cancer	0.00348	0.0117	CcSEcCtD
Linagliptin—Pain in extremity—Doxorubicin—liver cancer	0.0034	0.0114	CcSEcCtD
Linagliptin—Diarrhoea—Sorafenib—liver cancer	0.00334	0.0112	CcSEcCtD
Linagliptin—Nasopharyngitis—Epirubicin—liver cancer	0.00328	0.011	CcSEcCtD
Linagliptin—Pancreatitis—Epirubicin—liver cancer	0.00311	0.0104	CcSEcCtD
Linagliptin—Rash—Sorafenib—liver cancer	0.00308	0.0103	CcSEcCtD
Linagliptin—Dermatitis—Sorafenib—liver cancer	0.00308	0.0103	CcSEcCtD
Linagliptin—Headache—Sorafenib—liver cancer	0.00306	0.0103	CcSEcCtD
Linagliptin—Nasopharyngitis—Doxorubicin—liver cancer	0.00304	0.0102	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Epirubicin—liver cancer	0.00295	0.00991	CcSEcCtD
Linagliptin—Weight increased—Epirubicin—liver cancer	0.00289	0.0097	CcSEcCtD
Linagliptin—Pancreatitis—Doxorubicin—liver cancer	0.00288	0.00967	CcSEcCtD
Linagliptin—Infestation—Epirubicin—liver cancer	0.00283	0.0095	CcSEcCtD
Linagliptin—Infestation NOS—Epirubicin—liver cancer	0.00283	0.0095	CcSEcCtD
Linagliptin—Urinary tract infection—Epirubicin—liver cancer	0.00275	0.00924	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00273	0.00917	CcSEcCtD
Linagliptin—Weight increased—Doxorubicin—liver cancer	0.00267	0.00897	CcSEcCtD
Linagliptin—Infestation NOS—Doxorubicin—liver cancer	0.00262	0.00879	CcSEcCtD
Linagliptin—Infestation—Doxorubicin—liver cancer	0.00262	0.00879	CcSEcCtD
Linagliptin—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—CTNNB1—liver cancer	0.00258	0.0414	CbGpPWpGaD
Linagliptin—Urinary tract infection—Doxorubicin—liver cancer	0.00255	0.00855	CcSEcCtD
Linagliptin—CYP3A4—Liver X Receptor Pathway—SCD—liver cancer	0.00252	0.0404	CbGpPWpGaD
Linagliptin—DPP4—Incretin synthesis, secretion, and inactivation—CTNNB1—liver cancer	0.0023	0.0368	CbGpPWpGaD
Linagliptin—Immune system disorder—Epirubicin—liver cancer	0.0023	0.00771	CcSEcCtD
Linagliptin—Mediastinal disorder—Epirubicin—liver cancer	0.00229	0.00769	CcSEcCtD
Linagliptin—ABCB1—Drug Induction of Bile Acid Pathway—NR1H4—liver cancer	0.00226	0.0362	CbGpPWpGaD
Linagliptin—ABCB1—Drug Induction of Bile Acid Pathway—NR1I3—liver cancer	0.00222	0.0355	CbGpPWpGaD
Linagliptin—Malnutrition—Epirubicin—liver cancer	0.00221	0.00743	CcSEcCtD
Linagliptin—Back pain—Epirubicin—liver cancer	0.00214	0.00718	CcSEcCtD
Linagliptin—Immune system disorder—Doxorubicin—liver cancer	0.00212	0.00713	CcSEcCtD
Linagliptin—Mediastinal disorder—Doxorubicin—liver cancer	0.00212	0.00711	CcSEcCtD
Linagliptin—Malnutrition—Doxorubicin—liver cancer	0.00205	0.00687	CcSEcCtD
Linagliptin—Back pain—Doxorubicin—liver cancer	0.00198	0.00665	CcSEcCtD
Linagliptin—Cough—Epirubicin—liver cancer	0.00193	0.00648	CcSEcCtD
Linagliptin—Arthralgia—Epirubicin—liver cancer	0.00188	0.00632	CcSEcCtD
Linagliptin—Myalgia—Epirubicin—liver cancer	0.00188	0.00632	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00187	0.00628	CcSEcCtD
Linagliptin—Anaphylactic shock—Epirubicin—liver cancer	0.00181	0.00606	CcSEcCtD
Linagliptin—Infection—Epirubicin—liver cancer	0.00179	0.00602	CcSEcCtD
Linagliptin—Cough—Doxorubicin—liver cancer	0.00179	0.006	CcSEcCtD
Linagliptin—Skin disorder—Epirubicin—liver cancer	0.00175	0.00589	CcSEcCtD
Linagliptin—Myalgia—Doxorubicin—liver cancer	0.00174	0.00585	CcSEcCtD
Linagliptin—Arthralgia—Doxorubicin—liver cancer	0.00174	0.00585	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00173	0.00581	CcSEcCtD
Linagliptin—Anaphylactic shock—Doxorubicin—liver cancer	0.00167	0.00561	CcSEcCtD
Linagliptin—Infection—Doxorubicin—liver cancer	0.00166	0.00557	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00164	0.00552	CcSEcCtD
Linagliptin—Skin disorder—Doxorubicin—liver cancer	0.00162	0.00545	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Epirubicin—liver cancer	0.00156	0.00523	CcSEcCtD
Linagliptin—Constipation—Epirubicin—liver cancer	0.00154	0.00518	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00152	0.00511	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00144	0.00484	CcSEcCtD
Linagliptin—Urticaria—Epirubicin—liver cancer	0.00143	0.00481	CcSEcCtD
Linagliptin—Constipation—Doxorubicin—liver cancer	0.00143	0.0048	CcSEcCtD
Linagliptin—DPP4—Metabolism of proteins—ADAMTS17—liver cancer	0.00142	0.0228	CbGpPWpGaD
Linagliptin—CYP3A4—Drug Induction of Bile Acid Pathway—NR1H4—liver cancer	0.00139	0.0223	CbGpPWpGaD
Linagliptin—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I3—liver cancer	0.00137	0.0219	CbGpPWpGaD
Linagliptin—ABCB1—Constitutive Androstane Receptor Pathway—NR1I3—liver cancer	0.00134	0.0214	CbGpPWpGaD
Linagliptin—Hypersensitivity—Epirubicin—liver cancer	0.00133	0.00447	CcSEcCtD
Linagliptin—Urticaria—Doxorubicin—liver cancer	0.00133	0.00446	CcSEcCtD
Linagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H4—liver cancer	0.0013	0.0208	CbGpPWpGaD
Linagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—liver cancer	0.00127	0.0204	CbGpPWpGaD
Linagliptin—CYP3A4—Farnesoid X Receptor  Pathway—NR1H4—liver cancer	0.00127	0.0204	CbGpPWpGaD
Linagliptin—Diarrhoea—Epirubicin—liver cancer	0.00124	0.00415	CcSEcCtD
Linagliptin—Hypersensitivity—Doxorubicin—liver cancer	0.00123	0.00413	CcSEcCtD
Linagliptin—ABCB1—Constitutive Androstane Receptor Pathway—GSTA2—liver cancer	0.00119	0.0191	CbGpPWpGaD
Linagliptin—CYP3A4—Aflatoxin B1 metabolism—GSTM1—liver cancer	0.00117	0.0187	CbGpPWpGaD
Linagliptin—Diarrhoea—Doxorubicin—liver cancer	0.00114	0.00384	CcSEcCtD
Linagliptin—Rash—Epirubicin—liver cancer	0.00114	0.00382	CcSEcCtD
Linagliptin—Dermatitis—Epirubicin—liver cancer	0.00114	0.00382	CcSEcCtD
Linagliptin—Headache—Epirubicin—liver cancer	0.00113	0.0038	CcSEcCtD
Linagliptin—CYP3A4—Estrogen metabolism—GSTA1—liver cancer	0.00112	0.018	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—YIF1A—liver cancer	0.00108	0.0173	CbGpPWpGaD
Linagliptin—Rash—Doxorubicin—liver cancer	0.00105	0.00354	CcSEcCtD
Linagliptin—Dermatitis—Doxorubicin—liver cancer	0.00105	0.00353	CcSEcCtD
Linagliptin—Headache—Doxorubicin—liver cancer	0.00105	0.00351	CcSEcCtD
Linagliptin—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—liver cancer	0.000905	0.0145	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—EXOSC2—liver cancer	0.000887	0.0142	CbGpPWpGaD
Linagliptin—CYP3A4—Constitutive Androstane Receptor Pathway—NR1I3—liver cancer	0.000824	0.0132	CbGpPWpGaD
Linagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H4—liver cancer	0.000798	0.0128	CbGpPWpGaD
Linagliptin—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—liver cancer	0.000795	0.0127	CbGpPWpGaD
Linagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—liver cancer	0.000785	0.0126	CbGpPWpGaD
Linagliptin—DPP4—Peptide hormone metabolism—CTNNB1—liver cancer	0.000779	0.0125	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—NDRG1—liver cancer	0.000749	0.012	CbGpPWpGaD
Linagliptin—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—liver cancer	0.000734	0.0118	CbGpPWpGaD
Linagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.000706	0.0113	CbGpPWpGaD
Linagliptin—CYP3A4—Xenobiotics—CYP2E1—liver cancer	0.000665	0.0107	CbGpPWpGaD
Linagliptin—CYP3A4—Tamoxifen metabolism—CYP2E1—liver cancer	0.000639	0.0102	CbGpPWpGaD
Linagliptin—CYP3A4—Aflatoxin activation and detoxification—GGT1—liver cancer	0.000636	0.0102	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—IL12A—liver cancer	0.000594	0.00951	CbGpPWpGaD
Linagliptin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—liver cancer	0.000571	0.00915	CbGpPWpGaD
Linagliptin—CYP3A4—Estrogen metabolism—GSTM1—liver cancer	0.000548	0.00879	CbGpPWpGaD
Linagliptin—CYP3A4—Estrogen metabolism—CYP1A1—liver cancer	0.00052	0.00833	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—HNF4A—liver cancer	0.000519	0.00832	CbGpPWpGaD
Linagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.000507	0.00812	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—ATF3—liver cancer	0.000498	0.00798	CbGpPWpGaD
Linagliptin—CYP3A4—Irinotecan Pathway—APC—liver cancer	0.000498	0.00798	CbGpPWpGaD
Linagliptin—CYP3A4—Xenobiotics—CYP1A1—liver cancer	0.000478	0.00766	CbGpPWpGaD
Linagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000464	0.00743	CbGpPWpGaD
Linagliptin—CYP3A4—Tamoxifen metabolism—CYP1A1—liver cancer	0.000459	0.00736	CbGpPWpGaD
Linagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.000435	0.00697	CbGpPWpGaD
Linagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—liver cancer	0.000425	0.00681	CbGpPWpGaD
Linagliptin—CYP3A4—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.000411	0.00658	CbGpPWpGaD
Linagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000383	0.00614	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—UGDH—liver cancer	0.000374	0.00599	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—IL12B—liver cancer	0.000373	0.00597	CbGpPWpGaD
Linagliptin—CYP3A4—Tryptophan metabolism—CYP2E1—liver cancer	0.000341	0.00547	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—HMOX1—liver cancer	0.000338	0.00541	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—IGF2—liver cancer	0.000309	0.00495	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—MYO5B—liver cancer	0.000292	0.00468	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.000292	0.00468	CbGpPWpGaD
Linagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000286	0.00458	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—FST—liver cancer	0.000285	0.00457	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—TERT—liver cancer	0.000277	0.00444	CbGpPWpGaD
Linagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000276	0.00442	CbGpPWpGaD
Linagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000272	0.00437	CbGpPWpGaD
Linagliptin—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.000245	0.00393	CbGpPWpGaD
Linagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000236	0.00379	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—F2—liver cancer	0.000226	0.00362	CbGpPWpGaD
Linagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000224	0.00359	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—liver cancer	0.000222	0.00356	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.000218	0.0035	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—liver cancer	0.000218	0.00349	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.000215	0.00344	CbGpPWpGaD
Linagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—liver cancer	0.000213	0.00342	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.000212	0.00339	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—liver cancer	0.000203	0.00326	CbGpPWpGaD
Linagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000198	0.00318	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.000196	0.00314	CbGpPWpGaD
Linagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000196	0.00314	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000194	0.0031	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—MMP2—liver cancer	0.000192	0.00307	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000191	0.00306	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000184	0.00296	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000182	0.00292	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.00018	0.00288	CbGpPWpGaD
Linagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—liver cancer	0.000163	0.00261	CbGpPWpGaD
Linagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000161	0.00258	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—JUN—liver cancer	0.00016	0.00256	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000153	0.00245	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.00015	0.0024	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—CTNNB1—liver cancer	0.000147	0.00236	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000146	0.00234	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—liver cancer	0.000143	0.00229	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000143	0.00229	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—CASP3—liver cancer	0.000143	0.00229	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—IL2—liver cancer	0.000142	0.00228	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—liver cancer	0.00014	0.00224	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000137	0.00219	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000137	0.00219	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000129	0.00207	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	0.000123	0.00197	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—VEGFA—liver cancer	0.000121	0.00194	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000119	0.00191	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.000117	0.00188	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—TGFB1—liver cancer	0.000111	0.00178	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000109	0.00175	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	0.000108	0.00173	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	0.000106	0.00169	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—TNF—liver cancer	0.000104	0.00166	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—UGDH—liver cancer	0.000104	0.00166	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—liver cancer	9.99e-05	0.0016	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—GSTP1—liver cancer	9.8e-05	0.00157	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—EPT1—liver cancer	9.75e-05	0.00156	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	9.67e-05	0.00155	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—TAT—liver cancer	9.24e-05	0.00148	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—GSTM1—liver cancer	9.01e-05	0.00144	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—AKT1—liver cancer	8.92e-05	0.00143	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	8.89e-05	0.00142	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—CYP1A1—liver cancer	8.54e-05	0.00137	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	8.42e-05	0.00135	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	7.84e-05	0.00126	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	7.18e-05	0.00115	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	7.04e-05	0.00113	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	6.85e-05	0.0011	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	6.84e-05	0.0011	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	6.78e-05	0.00109	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	6.63e-05	0.00106	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	6.59e-05	0.00106	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	6.47e-05	0.00104	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—UGDH—liver cancer	6.39e-05	0.00102	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GLUL—liver cancer	6.28e-05	0.00101	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CPT1B—liver cancer	6.28e-05	0.00101	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—NR1H4—liver cancer	6.06e-05	0.000971	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—EPT1—liver cancer	6.01e-05	0.000963	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	5.97e-05	0.000957	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GSTA3—liver cancer	5.96e-05	0.000954	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	5.73e-05	0.000918	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—TAT—liver cancer	5.69e-05	0.000913	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	5.49e-05	0.000881	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	5.48e-05	0.000878	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GSTA4—liver cancer	5.45e-05	0.000873	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GSTA2—liver cancer	5.31e-05	0.000851	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GSTA1—liver cancer	5.12e-05	0.000821	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	5.12e-05	0.00082	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	5.08e-05	0.000814	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—NAT2—liver cancer	5.06e-05	0.000812	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ALDOB—liver cancer	4.85e-05	0.000778	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	4.66e-05	0.000748	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CRABP1—liver cancer	4.63e-05	0.000742	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	4.63e-05	0.000742	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	4.51e-05	0.000723	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—HPGDS—liver cancer	4.05e-05	0.000649	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CPT1B—liver cancer	3.87e-05	0.00062	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GLUL—liver cancer	3.87e-05	0.00062	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	3.81e-05	0.000611	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—NR1H4—liver cancer	3.73e-05	0.000598	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GSTA3—liver cancer	3.67e-05	0.000588	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PSMA4—liver cancer	3.61e-05	0.000578	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PSMD10—liver cancer	3.61e-05	0.000578	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GOT2—liver cancer	3.51e-05	0.000562	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	3.44e-05	0.000551	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GSTA4—liver cancer	3.36e-05	0.000538	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CYP2E1—liver cancer	3.3e-05	0.000529	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GSTA2—liver cancer	3.27e-05	0.000524	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GSTA1—liver cancer	3.16e-05	0.000506	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—NAT2—liver cancer	3.12e-05	0.0005	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	3.11e-05	0.000499	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CYCS—liver cancer	3.09e-05	0.000495	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GOT1—liver cancer	3.03e-05	0.000486	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GGT1—liver cancer	3.03e-05	0.000486	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ALDOB—liver cancer	2.99e-05	0.000479	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CRABP1—liver cancer	2.85e-05	0.000457	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GSTP1—liver cancer	2.72e-05	0.000436	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—HMOX1—liver cancer	2.68e-05	0.00043	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GSTM1—liver cancer	2.5e-05	0.000401	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—HPGDS—liver cancer	2.49e-05	0.0004	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CYP1A1—liver cancer	2.37e-05	0.00038	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PSMA4—liver cancer	2.22e-05	0.000356	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PSMD10—liver cancer	2.22e-05	0.000356	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—MTHFR—liver cancer	2.21e-05	0.000354	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PPARA—liver cancer	2.17e-05	0.000348	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GOT2—liver cancer	2.16e-05	0.000347	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CYP2E1—liver cancer	2.03e-05	0.000326	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CYCS—liver cancer	1.9e-05	0.000305	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GGT1—liver cancer	1.87e-05	0.000299	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GOT1—liver cancer	1.87e-05	0.000299	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PIK3CG—liver cancer	1.86e-05	0.000298	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PPARG—liver cancer	1.79e-05	0.000287	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GSTP1—liver cancer	1.68e-05	0.000269	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—HMOX1—liver cancer	1.65e-05	0.000265	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PIK3CD—liver cancer	1.63e-05	0.000262	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ALB—liver cancer	1.61e-05	0.000258	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GSTM1—liver cancer	1.54e-05	0.000247	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CYP1A1—liver cancer	1.46e-05	0.000234	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PIK3CB—liver cancer	1.42e-05	0.000228	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—MTHFR—liver cancer	1.36e-05	0.000218	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PPARA—liver cancer	1.34e-05	0.000214	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PIK3CG—liver cancer	1.14e-05	0.000183	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PPARG—liver cancer	1.1e-05	0.000177	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PIK3CD—liver cancer	1.01e-05	0.000161	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ALB—liver cancer	9.93e-06	0.000159	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PIK3CB—liver cancer	8.77e-06	0.00014	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PIK3CA—liver cancer	8.67e-06	0.000139	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—AKT1—liver cancer	7.09e-06	0.000114	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PIK3CA—liver cancer	5.34e-06	8.56e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—AKT1—liver cancer	4.37e-06	7e-05	CbGpPWpGaD
